WOONSOCKET, R.I., Jan. 3, 2025 /PRNewswire/ — CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on February 3, 2025, to holders of record on January 23, 2025.… Continue reading CVS Health announces quarterly dividend
Tag: People
Corporate Training Market size to increase by USD 43.86 Billion between 2024 to 2029, Market Segmentation by Product, Type, Geography , Technavio
NEW YORK, Jan. 3, 2025 /PRNewswire/ — The global corporate training market size is estimated to grow by USD 43.86 billion from 2025 to 2029, according to Technavio. The market is estimated to grow at a CAGR of 7.8% during the forecast period. The report provides a comprehensive forecast of key segments below- Segmentation Overview Continue Reading… Continue reading Corporate Training Market size to increase by USD 43.86 Billion between 2024 to 2029, Market Segmentation by Product, Type, Geography , Technavio
Bloomberg Law 2024 League Tables Reveal Top 20 M&A Law Firms
ARLINGTON, Va., Jan. 3, 2025 /PRNewswire/ — Today, Bloomberg Law published league tables for 2024, finding that Kirkland & Ellis retained its crown as Big Law’s top mergers and acquisitions adviser, guiding global deals worth about $427 billion. Kirkland topped rivals Latham & Watkins ($367 billion), Skadden Arps Slate Meagher & Flom ($361 billion), Freshfields ($264 billion), and… Continue reading Bloomberg Law 2024 League Tables Reveal Top 20 M&A Law Firms
Allies Against Slavery Launches Next Generation of Lighthouse Data Platform and Insights to Combat Human Trafficking
AUSTIN, Texas, Jan. 3, 2025 /PRNewswire/ — Allies Against Slavery (Allies) announced today the launch of the latest version of its groundbreaking data platform, Lighthouse. This innovative tool, now featuring victim screening data from three states, data from Federal Human Trafficking cases, state policy data and other sources, is designed to provide critical information and… Continue reading Allies Against Slavery Launches Next Generation of Lighthouse Data Platform and Insights to Combat Human Trafficking
Stroock Law Firm Settlement With Creditors Has Gone Effective
NEW YORK, Jan. 3, 2025 /PRNewswire/ — Stroock & Stroock & Lavan LLP (“Stroock”) is pleased to advise that it has reached settlements with all of its major creditors which will allow for the consensual and orderly completion of its out of court winddown and the distribution of its assets. Stroock entered into dissolution effective… Continue reading Stroock Law Firm Settlement With Creditors Has Gone Effective
Zhi: Embracing the intelligent era, elevating people’s wisdom
BEIJING, Jan. 3, 2025 /PRNewswire/ — A news report from China.org.cn on the Chinese character of the year: If one asks ChatGPT about “Zhi (meaning intelligent)”, the 2024 Chinese character of the year, it will probably answer with this: The character “Zhi” has two particles, “Zhi (a different Chinese character with similar pronunciation)”, which means to… Continue reading Zhi: Embracing the intelligent era, elevating people’s wisdom
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2025 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (“Rigel”) (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel’s Board of Directors and granted as an inducement material to employees’ entering into employment with Rigel, in accordance… Continue reading Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025
MIAMI, Jan. 3, 2025 /PRNewswire/ — HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) subsidiary, is inviting Qualified Institutional Investors to an investor workshop to support planned acquisitions for a national network of interventional psychiatry practices focused on treatment suicidal depression and PTSD. The Company has previously announced non-binding Letters of Intent and banking… Continue reading HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025
The D. E. Shaw Group Releases Open Letter to the Board of Directors of Air Products and Chemicals
Expresses Disappointment with the Board’s Failure to Manage an Effective CEO Succession Process Announces Intention to Support Change at the 2025 Annual Meeting NEW YORK, Jan. 3, 2025 /PRNewswire/ — The D. E. Shaw group (“D. E. Shaw”), a global investment and technology development firm with more than $65 billion in investment capital and a… Continue reading The D. E. Shaw Group Releases Open Letter to the Board of Directors of Air Products and Chemicals
Atlanta Housing Progresses Bowen Homes Phase I
Financial closing launches community transformation with 151 mixed-income units ATLANTA, Jan. 3, 2025 /PRNewswire/ — Atlanta Housing (AH), in collaboration with Invest Atlanta, the City of Atlanta, the Georgia Department of Community Affairs, the U.S. Department of Housing and Urban Development (HUD), and development partner McCormack Baron Salazar, announce the financial closing of Bowen Homes… Continue reading Atlanta Housing Progresses Bowen Homes Phase I